JPH0144169B2 - - Google Patents

Info

Publication number
JPH0144169B2
JPH0144169B2 JP12572583A JP12572583A JPH0144169B2 JP H0144169 B2 JPH0144169 B2 JP H0144169B2 JP 12572583 A JP12572583 A JP 12572583A JP 12572583 A JP12572583 A JP 12572583A JP H0144169 B2 JPH0144169 B2 JP H0144169B2
Authority
JP
Japan
Prior art keywords
compound
lower alkyl
opioid
alkyl group
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP12572583A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6016997A (ja
Inventor
Norihiro Kakimoto
Takashi Katayama
Tadahiko Hasato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asai Germanium Research Institute
Original Assignee
Asai Germanium Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asai Germanium Research Institute filed Critical Asai Germanium Research Institute
Priority to JP12572583A priority Critical patent/JPS6016997A/ja
Priority to CH315384A priority patent/CH660192B/fr
Priority to GB08416614A priority patent/GB2142635B/en
Priority to FR8410392A priority patent/FR2548187B1/fr
Priority to DE3424107A priority patent/DE3424107A1/de
Priority to US06/626,787 priority patent/US4681960A/en
Publication of JPS6016997A publication Critical patent/JPS6016997A/ja
Priority to US06/930,561 priority patent/US4748187A/en
Publication of JPH0144169B2 publication Critical patent/JPH0144169B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
JP12572583A 1983-07-01 1983-07-11 オピオイド分解酵素阻害剤 Granted JPS6016997A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP12572583A JPS6016997A (ja) 1983-07-11 1983-07-11 オピオイド分解酵素阻害剤
CH315384A CH660192B (enExample) 1983-07-01 1984-06-29
GB08416614A GB2142635B (en) 1983-07-01 1984-06-29 Organogermanium compound and an opioid peptide-degrading enzyme inhibitor containing the same
FR8410392A FR2548187B1 (fr) 1983-07-01 1984-06-29 Composes d'organo-germanium et leurs utilisations therapeutiques en tant qu'inhibiteurs des enzymes qui degradent les peptides opioides
DE3424107A DE3424107A1 (de) 1983-07-01 1984-06-29 Organogermaniumverbindung und diese als wirkstoff enthaltender opioidpeptidaseinhibitor
US06/626,787 US4681960A (en) 1983-07-01 1984-07-02 Organogermanium compound
US06/930,561 US4748187A (en) 1983-07-01 1986-11-14 Opioid peptide-degrading enzyme inhibitor with a germanium compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12572583A JPS6016997A (ja) 1983-07-11 1983-07-11 オピオイド分解酵素阻害剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP61296117A Division JPS62142189A (ja) 1986-12-12 1986-12-12 有機ゲルマニウム化合物

Publications (2)

Publication Number Publication Date
JPS6016997A JPS6016997A (ja) 1985-01-28
JPH0144169B2 true JPH0144169B2 (enExample) 1989-09-26

Family

ID=14917224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12572583A Granted JPS6016997A (ja) 1983-07-01 1983-07-11 オピオイド分解酵素阻害剤

Country Status (1)

Country Link
JP (1) JPS6016997A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61254631A (ja) * 1985-05-04 1986-11-12 Nippon Zeon Co Ltd 感光性フレキソ版とゴムバツキング材との接着方法
JPS6293293A (ja) * 1985-10-18 1987-04-28 Asai Gerumaniumu Kenkyusho:Kk 有機ゲルマニウム化合物及びそれを主剤とした鎮痛剤
JP2009114028A (ja) * 2007-11-07 2009-05-28 Olympus Corp ガラスセルの製造方法、ガラスセル成形装置

Also Published As

Publication number Publication date
JPS6016997A (ja) 1985-01-28

Similar Documents

Publication Publication Date Title
EP0082088B1 (fr) Nouveaux dérivés d'aminoacides, et leur application thérapeutique
EP0274453A2 (fr) Nouveaux composés à activité d'inhibiteurs de collagénase, procédé pour les préparer et compositions pharmaceutiques contenant ces composés
CA1183140A (fr) Procede de preparation d'acides aza-bicyclo-octane carboxyliques
FR2501199A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
SU1604158A3 (ru) Способ получени производных гризеоловой кислоты
JPS6229566A (ja) 新規グアニジノメチル安息香酸誘導体
JPH03112933A (ja) 抗腫瘍剤
DK173952B1 (da) Anvendelse af spergualinderivater til fremstilling af lægemidler med immunosuppressiv virkning
EP0005658A1 (fr) Nouveaux dérivés de peptides analogues des enképhalines, leur procédé de préparation et leur application thérapeutique
EP0046113A1 (fr) Nouveaux peptides et leur application en thérapeutique
US4748187A (en) Opioid peptide-degrading enzyme inhibitor with a germanium compound
EP0282374A1 (fr) Nouveaux dérivés peptidiques à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2483929A1 (fr) Nouvelles adenosines n6-substituees utiles comme medicaments antihypertenseurs, compositions therapeutiques et formes pharmaceutiques les contenant, et leur procede de preparation
CH661661A5 (fr) Agent antineoplasique.
JPS6016997A (ja) オピオイド分解酵素阻害剤
EP0772630B1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
JPH0348200B2 (enExample)
JP2569060B2 (ja) グルタミルシスティン誘導体、その製造法およびそれを有効成分とする組織グルタチオンレベル向上剤
JPH031319B2 (enExample)
US5475028A (en) 2-aminoethanesulfonic acid zinc complex
JPH05331063A (ja) エンドセリン受容体拮抗剤
JPH04264092A (ja) シクロトリホスファゼンのｎ，ｏスピロ環状誘導体とその製法および用途
BE839405A (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
EP0275221B1 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant
FR2593813A1 (fr) Derives des na-arylsulfonylaminoacyl p-amidinophenylalaninamides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant